4//SEC Filing
Cranston Lynda Sarah 4
Accession 0000905718-18-000013
CIK 0001498382other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 4:57 PM ET
Size
4.9 KB
Accession
0000905718-18-000013
Insider Transaction Report
Form 4
Cranston Lynda Sarah
Director
Transactions
- Other
Common Stock
2017-12-31$3.20/sh+71$227→ 2,557 total(indirect: by J.G. Cranston & Associates, Inc.)
Footnotes (1)
- [F1]The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock.
Documents
Issuer
DelMar Pharmaceuticals, Inc.
CIK 0001498382
Entity typeother
Related Parties
1- filerCIK 0001633660
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 4:57 PM ET
- Size
- 4.9 KB